1. Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer
   Shaoxiang Wang et al, 2015, Journal of Cancer Research and Clinical Oncology CrossRef
2. A Novel Porphyromonas gingivalis Infection-Related Inflammatory Response-Related Genes Signature Predicts the Prognosis of Esophageal Squamous Cell Carcinoma
   Jinyu Kong et al, 2024, Clinical Medicine Insights: Oncology CrossRef
3. Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma
   Rong Qiu et al, 2022, Molecular Biology Reports CrossRef
4. Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma
   Juliann E. Kosovec et al, 2016, Annals of Surgery CrossRef
5. Irradiation facilitates the inhibitory effect of the heat shock protein 90 inhibitor NVP-BEP800 on the proliferation of malignant glioblastoma cells through attenuation of the upregulation of heat shock protein 70
   JIANYUE WU et al, 2014, Experimental and Therapeutic Medicine CrossRef
6. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells
   YUTING LIU et al, 2015, International Journal of Oncology CrossRef
7. Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma
   Tomoki Shirota et al, 2015, Molecular Cancer Therapeutics CrossRef
8. Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models
   Eun Ju Shin et al, 2018, Biochemical Pharmacology CrossRef
9. AUY922 induces retinal toxicity through attenuating TRPM1
   Che-Hung Shen et al, 2021, Journal of Biomedical Science CrossRef
10. Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
    Chang Gao et al, 2019, Current Pharmaceutical Design CrossRef
11. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway
    TAKASHI UI et al, 2014, Oncology Reports CrossRef